)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
Sol-Gel Technologies
Sol-Gel Technologies (SLGL) investor relations material
Sol-Gel Technologies Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary28 May, 2026
Executive summary
Received Notice of Allowance for a method-of-use patent for SGT-610, extending protection until 2044.
Completed an oversubscribed underwritten offering, raising $33.1 million in gross proceeds.
Entered an exclusive license agreement with Sun Pharma for TWYNEO commercialization in India.
Pivotal Phase 3 trial of SGT-610 for Gorlin syndrome ongoing, with top-line results expected Q4 2026.
Financial highlights
Q1 2026 revenue was $0.1 million, down from $1.0 million in Q1 2025, mainly due to a prior milestone payment.
Research and development expenses decreased to $2.8 million from $8.8 million year-over-year.
Net loss for Q1 2026 was $3.7 million ($1.31 per share), improved from $8.8 million ($3.2 per share) in Q1 2025.
Cash, cash equivalents, and deposits totaled $10.1 million, with $42.7 million in marketable securities as of March 31, 2026.
Outlook and guidance
Cash resources expected to fund operations into Q1 2028.
Top-line results for SGT-610 Phase 3 trial anticipated in Q4 2026.
TWYNEO and EPSOLAY launches in new territories expected in 2028 and 2027, respectively.
Annual royalty revenue from new agreements could reach $10 million by 2031.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sol-Gel Technologies
- 2025 revenue grew to $19.4M, net loss narrowed, and SGT-610 Phase 3 trial reached full enrollment.SLGL
Q4 202519 Mar 2026 - SGT-610 aims to be the first preventive therapy for Gorlin syndrome, targeting a $600M+ market.SLGLCorporate presentation16 Mar 2026
- Dermatology innovator seeks up to $120M via shelf registration after global licensing and share split.SLGLRegistration Filing16 Dec 2025
- Q3 2025 featured higher R&D costs, expanded licensing, and a net loss amid global growth plans.SLGLQ3 202520 Nov 2025
- Revenue surged to $11.5M in 2024 as net loss narrowed and key U.S. assets were monetized.SLGLQ4 202410 Sep 2025
- Q2 2025 revenue jumped to $17.2M and net income hit $11.6M, with cash runway into 2027.SLGLQ2 202519 Aug 2025
- Revenue up, net loss down, and pipeline plus licensing deals drive future growth.SLGLQ3 202413 Jun 2025
- Q2 revenue jumped to $5.4M with net income of $2.0M, extending cash runway into 2026.SLGLQ2 202413 Jun 2025
- Revenue up, losses widen as R&D accelerates; cash runway into 2027 amid industry risks.SLGLQ1 20256 Jun 2025
Next Sol-Gel Technologies earnings date
Q2 202610 Aug, 2026
Sol-Gel Technologies
Next Sol-Gel Technologies earnings date
Q2 202610 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage